Nikko Asset Management Americas, Inc. Crispr Therapeutics Ag Transaction History

Nikko Asset Management Americas, Inc.

  • $9.43 Billion
  • Q2 2025

A detailed history of Nikko Asset Management Americas, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,414,271 shares of CRSP stock, worth $137 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
2,414,271
Previous 2,539,889 4.95%
Holding current value
$137 Million
Previous $86.4 Million 35.86%
% of portfolio
1.25%
Previous 1.16%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$31.27 - $48.64 $3.93 Million - $6.11 Million
-125,618 Reduced 4.95%
2,414,271 $117 Million
Q1 2025

May 07, 2025
SELL
$34.03 - $53.02 $7 Million - $10.9 Million
-205,787 Reduced 7.49%
2,539,889 $86.4 Million
Q4 2024

Feb 10, 2025
SELL
$38.65 - $55.15 $8.56 Million - $12.2 Million
-221,543 Reduced 7.47%
2,745,676 $108 Million
Q3 2024

Nov 07, 2024
SELL
$44.62 - $62.75 $8.22 Million - $11.6 Million
-184,295 Reduced 5.85%
2,967,219 $139 Million
Q2 2024

Aug 09, 2024
SELL
$51.17 - $68.18 $6 Million - $8 Million
-117,271 Reduced 3.59%
3,151,514 $170 Million
Q1 2024

May 02, 2024
SELL
$60.67 - $89.12 $6.13 Million - $9 Million
-100,977 Reduced 3.0%
3,268,785 $223 Million
Q4 2023

Feb 08, 2024
SELL
$38.62 - $72.18 $3.7 Million - $6.91 Million
-95,708 Reduced 2.76%
3,369,762 $211 Million
Q3 2023

Nov 09, 2023
SELL
$45.39 - $59.0 $3.08 Million - $4.01 Million
-67,887 Reduced 1.92%
3,465,470 $157 Million
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $19.1 Million - $29.7 Million
-438,782 Reduced 11.05%
3,533,357 $198 Million
Q1 2023

May 03, 2023
SELL
$41.0 - $56.12 $1.41 Million - $1.93 Million
-34,337 Reduced 0.86%
3,972,139 $180 Million
Q4 2022

Feb 13, 2023
SELL
$39.19 - $65.67 $10 Million - $16.8 Million
-256,260 Reduced 6.01%
4,006,476 $163 Million
Q3 2022

Nov 14, 2022
SELL
$61.1 - $83.78 $19.6 Million - $26.9 Million
-321,362 Reduced 7.01%
4,262,736 $277 Million
Q2 2022

Aug 04, 2022
SELL
$43.23 - $73.83 $1.54 Million - $2.63 Million
-35,649 Reduced 0.77%
4,584,098 $276 Million
Q1 2022

May 06, 2022
BUY
$53.19 - $79.24 $16 Million - $23.8 Million
300,276 Added 6.95%
4,619,747 $291 Million
Q4 2021

Feb 08, 2022
BUY
$70.09 - $111.29 $72.2 Million - $115 Million
1,029,955 Added 31.31%
4,319,471 $331 Million
Q3 2021

Nov 09, 2021
SELL
$110.2 - $156.64 $10.4 Million - $14.7 Million
-93,940 Reduced 2.78%
3,289,516 $368 Million
Q2 2021

Aug 09, 2021
SELL
$100.84 - $161.89 $27.9 Million - $44.7 Million
-276,409 Reduced 7.55%
3,383,456 $548 Million
Q1 2021

May 03, 2021
SELL
$110.72 - $210.04 $19.6 Million - $37.2 Million
-176,958 Reduced 4.61%
3,659,865 $446 Million
Q4 2020

Feb 11, 2021
BUY
$79.67 - $173.23 $11.1 Million - $24.1 Million
139,156 Added 3.76%
3,836,823 $587 Million
Q3 2020

Nov 02, 2020
SELL
$78.5 - $100.64 $1.12 Million - $1.44 Million
-14,303 Reduced 0.39%
3,697,667 $309 Million
Q2 2020

Aug 07, 2020
SELL
$38.5 - $76.05 $2.1 Million - $4.15 Million
-54,571 Reduced 1.45%
3,711,970 $269 Million
Q1 2020

Apr 30, 2020
BUY
$33.68 - $62.53 $24.1 Million - $44.8 Million
716,988 Added 23.51%
3,766,541 $160 Million
Q4 2019

Feb 06, 2020
BUY
$36.68 - $73.13 $9.98 Million - $19.9 Million
272,139 Added 9.8%
3,049,553 $186 Million
Q3 2019

Oct 29, 2019
BUY
$40.99 - $52.56 $37.1 Million - $47.6 Million
906,006 Added 48.41%
2,777,414 $114 Million
Q2 2019

Jul 29, 2019
BUY
$35.45 - $48.2 $50.7 Million - $68.9 Million
1,430,364 Added 324.31%
1,871,408 $88.1 Million
Q1 2019

Apr 30, 2019
BUY
$28.02 - $40.87 $12.3 Million - $18 Million
440,120 Added 47632.03%
441,044 $15.8 Million
Q4 2018

Feb 08, 2019
SELL
$22.73 - $42.34 $4,546 - $8,468
-200 Reduced 17.79%
924 $26,000
Q3 2018

Oct 15, 2018
BUY
$44.35 - $65.71 $49,849 - $73,858
1,124 New
1,124 $50,000

Others Institutions Holding CRSP

# of Institutions
527
Shares Held
68.6M
Call Options Held
3.67M
Put Options Held
2.25M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.42B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email